Printer Friendly

Panel steps up cancer war.

Panel steps up cancer war

The National Cancer Advisory Board, a presidentially appointed panel advising the National Cancer Institute, wants tobacco regulated as a drug. This is one of a series of recommendations it issued this week aimed at cutting the U.S. cancer death rate in half by the year 2000.

Eliminating smoking tops the board's list of prevention recommendations. Smoking accounts for 30 percent of all U.S. cancer deaths, including 87 percent of all lung cancer deaths, according to the Department of Health and Human Services. The advisory panel supports a smoking ban on all airline flights and asks Congress to classify tobacco as a drug, putting it under the regulatory aegis of the Food and Drug Administration. Special efforts should be made to deter children from smoking or chewing tobacco, the panel says, noting that 100,000 kids under 12 use tobacco.

Screening tests for breast, cervical and colorectal cancer should be readily available, says the panel. In particular, it notes, widespread use of mammography among women aged 40 and older could reduce breast cancer deaths by 50 percent. Yet many physicians do not routinely suggest mammography to patients at risk of breast cancer, the group says.

The panel urges schools, state and local governments, and even employers to help in the battle against cancer. But it also calls on individuals to adopt a healthier lifestyle, recommending that people reduce their fat intake to 30 percent of daily calories or less and get more fiber by eating fruits, vegetables and grains.

Cancer is the second leading cause of death in the United States, and is expected to kill about 502,000 people in 1989, according to the American Cancer Society.
COPYRIGHT 1989 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1989, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:National Cancer Advisory Board
Publication:Science News
Date:Feb 11, 1989
Words:284
Previous Article:NIH finds scientific errors but no fraud.
Next Article:Puzzling pulses form a star cluster's core.
Topics:


Related Articles
Cancer statistics: pluses and minuses.
NIH panel okays human gene transfer test.
Silicone breast implants on trial.
Gene-transfer trial begins in humans.
Tamoxifen and informed consent dissent: Congress, outside advisers cite reservations about NIH cancer-prevention trial.
The mandate for investigational cancer therapies.
Update in the mammogram debate.
NEW BREAST CANCER HOPE; FDA PANEL BACKS DRUGS TO PREVENT, ATTACK DISEASE.
IN YOUR 40S? GET A MAMMOGRAM : ACTIVISTS PRAISE GOVERNMENT DECISION TO SUPPORT BREAST-CANCER SCREENING.
Why we are still losing the winnable cancer war.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters